Quick Search

PHDS HEALTHCARE RESEARCH Co., Ltd. (CRO) is a CRO company serving the world, a national high-tech enterprise, and one of the leading contract research institutions (Contract Research Organization) in the industry.

搜索历史清除全部记录
最多显示8条历史搜索记录噢~
All
  • All
  • Product Management
  • News

The Wuxi Global Oral Forum and the High-Quality Development Conference of the China Food and Drug Promotion Association -- Bo Shi Zhi Xing was elected as an executive council unit and an excellent member unit.


Release time:

2024-03-28

On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.

The Wuxi Global Oral Forum and the High-Quality Development Conference of the China Food and Drug Promotion Association -- Bo Shi Zhi Xing was elected as an executive council unit and an excellent member unit.

On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and hosted by the China Food and Drug Promotion Association and organized by the Oral Health Committee of the China Food and Drug Promotion Association, was grandly held at the Wuxi International Conference Center. Attendees at the opening ceremony included Academicians Chen Wei, Gu Xiaosong, and Yang Shengli from the Chinese Academy of Engineering, Academicians Huang Zhengming and Mao Zhenbin from the United Nations International Academy of Ecological Life Safety, Academician Zhou Guohui from the Hong Kong Academy of Medicine, as well as 11 other Chinese and foreign academicians including Chen Zeliang and Lu Jiahai; Mr. Patrick Loh, President of the Asia-Pacific Region of the world's top 500 medical device company, Striker Group, and Dr. Alexander Ochsner, CEO of the International Team for Implantology (ITI); renowned experts and scholars from Peking University, Shandong University, Sichuan University, Shanghai Jiao Tong University, and Chulalongkorn University in Thailand. More than a thousand experts, scholars, and entrepreneur representatives from the food and drug industry attended the opening ceremony.

 After the election of attending members, Bo Shizhi Xing stood out among many enterprises. Our company's chairman was elected as the executive director of this session of the promotion association, and as one of the 20 award-winning enterprises, Bo Shizhi Xing received the honorary title of 'Outstanding Member Unit'. This honor will surely inspire all employees of Bo Shizhi Xing to contribute their part to promoting the country's high-quality development and to the development of new productive forces!

Academician Mao Zhenbin, President of the China Food and Drug Promotion Association, stated in his opening speech that the 20th National Congress of the Communist Party of China scientifically planned the major policies and goals for the development of the Party and the country in the coming period, making a series of major deployments around accelerating the construction of a new development pattern and promoting high-quality development.

The 2024 'Two Sessions' emphasized that innovation-led new productive forces should promote the country's high-quality development. The quality and safety of food and drugs are important foundations and guarantees for the physical and mental health and life safety of the people, and are a true reflection of the governance system and governance capacity of the Party and the country in the new era; they are also important indicators of the level of national economic and social development and the improvement of people's quality of life. The responsibilities of the China Food and Drug Promotion Association are closely related to national security, public governance, and basic livelihood guarantees, which is a very important link. We must firmly grasp high-quality development as the primary task, base ourselves on the new development position, implement the new development concept, clarify our responsibilities, enhance innovation capabilities, and promote high-quality development in the food and drug sector, which has significant practical and long-term significance for promoting the strategy of big health development.

The main content of the China Food and Drug Promotion Association High-Quality Development Conference includes a working exchange meeting for branch representative institutions and the second council meeting of the second session. More than 50 heads of established and proposed branch representative institutions and enterprise representatives attended the meeting, focusing on issues and engaging in extensive and in-depth exchanges and discussions based on their respective subfields. The second council meeting of the China Food and Drug Promotion Association voted to approve more than 20 established work rules and institutional documents, as well as related matters such as appointing honorary presidents of the association. President Mao Zhenbin delivered a work report to the council, proposing the goals and specific measures for the association to implement high-quality development, with the basic idea of 'Five Talks, Four Beauties, Three Loves' as the foundation of the association's culture, systematically sorting out and top-level designing future development strategies, and proposing an overall development strategy: '1236999 Project', showcasing a new look of high-quality development for the China Food and Drug Promotion Association.

The China Food and Drug Promotion Association plans in the overall situation, promotes in the trend, and acts on major issues, opening a new chapter in entrepreneurship on the new journey in the new era.

Keyword:

Relevant regulations and policies


Key points and judgment principles for the quality management of non-clinical research of drugs

In order to standardize the on-site inspection work of Good Laboratory Practice (GLP) for non-clinical drug research and improve inspection quality, the "Key Points and Determination Principles for the Inspection of Good Laboratory Practice in Non-Clinical Drug Research" has been formulated in accordance with relevant requirements such as the "Drug Administration Law of the People's Republic of China," "Good Laboratory Practice for Non-Clinical Drug Research," and "Management Measures for the Certification of Good Laboratory Practice for Non-Clinical Drug Research."

2024-11-22

Technical requirements for the latest declaration data electronic disc

In order to further improve the quality and efficiency of the preparation of electronic application materials for drug registration, and to standardize the management of electronic application materials, our center has updated the "Technical Requirements for Electronic Discs of Application Materials" and "Structure of Electronic Documents for Drug Registration Applications" published on December 2, 2022, based on feedback.

2024-11-22

PHDS was elected as: Vice President unit of the China Food and Drug Enterprise Quality Safety Promotion Association

In December 2023, PHDS HEALTHCARE RESEARCH Co., Ltd. was elected as the vice president unit of the China Food and Drug Enterprise Quality Safety Promotion Association, as well as the vice chairman of its subordinate digital professional committee (Certificate No.: Zhong Shi Yao An Cu Hui Zheng Zi 798). The election and award ceremony took place at the Three Gorges Hospital of Chongqing Medical University.

2024-11-22

The Wuxi Global Oral Forum and the High-Quality Development Conference of the China Food and Drug Promotion Association -- Bo Shi Zhi Xing was elected as an executive council unit and an excellent member unit.

On March 26-27, 2024, the China Wuxi Global Oral Forum and the China Food and Drug Promotion Association High-Quality Development Conference, guided by the Wuxi Municipal People's Government and the Wuxi Council for the Promotion of International Trade, and organized by the China Food and Drug Promotion Association and the Oral Health Committee of the China Food and Drug Promotion Association, will be grandly held at the Wuxi International Conference Center.

2024-11-22